darapladib

Update on Glaxo's Darapladib
Update on Glaxo's Darapladib
Yahoo/Zacks
GSK
darapladib
Flag link:
GlaxoSmithKline's blockbuster dreams dashed as darapladib goes 0-for-2 in PhIII
GlaxoSmithKline's blockbuster dreams dashed as darapladib goes 0-for-2 in PhIII
Fierce Biotech
GSK
darapladib
Flag link:
Tale Of Two Heart Drugs Show Challenges And Rewards In R&D
Tale Of Two Heart Drugs Show Challenges And Rewards In R&D
Forbes
LCZ696
Novartis
heart failure
darapladib
R&D
heart disease
GSK
Flag link:
Glaxo's Utter Stinkbomb Of A Drug
Glaxo's Utter Stinkbomb Of A Drug
Forbes
GSK
darapladib
Flag link:
GSK CEO says success of heart drug 'an open question'
GSK CEO says success of heart drug 'an open question'
Yahoo/Reuters
GSK
Pharma CEOs
darapladib
Andrew Witty
heart attack
Flag link:
Glaxo’s Darapladib Fails to Prevent Heart Attacks in Test
Glaxo’s Darapladib Fails to Prevent Heart Attacks in Test
Bloomberg
GSK
darapladib
heart attacks
Flag link:
Crunch time for GlaxoSmithKline's big heart drug bet
Crunch time for GlaxoSmithKline's big heart drug bet
Yahoo/Reuters
GSK
darapladib
Flag link:
Glaxo’s Drug Approvals Boost Morale as China Probe Drags
Glaxo’s Drug Approvals Boost Morale as China Probe Drags
Bloomberg
GSK
China
darapladib
MAGE-A3
Flag link:
Blockbuster buzz: 15 top therapies in late-stage development
Blockbuster buzz: 15 top therapies in late-stage development
Fierce Biotech
vortioxetine
Vectura
tofacitinib
Takeda
T-DM1
Sanofi
Roche
REGN727
Regeneron
Reata
QVA149
Pfizer
Odanacatib
Novartis
MorphoSys
Merck
macitentan
Lundbeck
Immunogen
GSK
GS-7977
Gilead
gantenerumab
Eliquis
darapladib
Bristol-Myers Squibb
Biogen Idec
BG-12
Bayer
Bardoxolone
Anacetrapib
Alpharadin
Algeta
Actelion
AbbVie
Flag link:
Big Pharma betting billions in high-stakes hunt for the next Lipitor
Big Pharma betting billions in high-stakes hunt for the next Lipitor
Fierce Biotech
Big Pharma
Lipitor
Anacetrapib
Merck
Plavix
Pfizer
Bristol-Myers Squibb
PCSK9 inhibitor
Sanofi
Regeneron
darapladib
Roche
GSK
Flag link:
HGSI Will Take Massive Hit If Albiglutide, Darapladib Fail
HGSI Will Take Massive Hit If Albiglutide, Darapladib Fail
Seeking Alpha
Human Genome Sciences
albiglutide
darapladib
Emergent BioSolutions
diabetes
Biogen Idec
lupus
Flag link:
Anthera's Lead Drug: A High-Risk, High-Reward Proposition
Anthera's Lead Drug: A High-Risk, High-Reward Proposition
Seeking Alpha
Anthera
A-002
acute coronary syndrome
GSK
darapladib
Flag link:
Glaxo's Radical Heart Drug
Glaxo's Radical Heart Drug
Forbes
GSK
darapladib
Flag link:
Study sharpens focus on Glaxo's heart drug hope
Study sharpens focus on Glaxo's heart drug hope
Reuters
GSK
darapladib
Flag link:
Glaxo places big bet on drug for clogged arteries
Glaxo places big bet on drug for clogged arteries
Reuters
GSK
darapladib
Flag link: